SBIR Phase I: User Application and Backend Portal to Enhance and Measure Addiction Treatment and Recovery Efficacy

SBIR 第一阶段：用户应用程序和后端门户，以增强和衡量成瘾治疗和康复效果

• 批准号: 1721733
• 负责人: Christopher Pesce
• 金额: $ 22.5万
• 依托单位: Sober Grid, Inc.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-01 至 2018-05-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1721733&HistoricalAwards=false
• 关键词: SBIR; Phase; User; Application; Backend

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to investigate the feasibility of enhancing the core individual user application and commercial backend portal products as required to enhance and measure the efficacy of innovative addiction treatment and recovery support tools. If successful, the investment will enable healthcare stakeholders (e.g., individuals, addiction and mental health institutions and providers, health researchers and universities, government agencies, and payers) to leverage technology-enhanced addiction treatment innovations such as mindfulness training, contingency management, medication-assisted treatment, peer support, and adaptive interventions that show promise for improving health outcomes and delivery efficiencies. The proposed innovation will help to determine the feasibility of developing, testing, and commercializing innovative technologies that improve the efficacy of existing health IT solutions and to create new solutions for the range of stakeholders exhibiting increasingly high demand for effective interventions and tools required to develop, provide, and assess effective addiction treatment and recovery support services in a mix of research and delivery settings and the ability to generate significant revenue across the mix of public and private addiction recovery delivery settings.The proposed project will entail rapidly assembling the technical foundation and then testing the feasibility of supporting deployment and assessment of novel, evidence-based addiction treatment strategies and recovery interventions. There are four key research objectives: (1) design, develop, and test a mechanism to create statistically significant cohorts; (2) discern and test methods to measure participant recovery and sobriety success; (3) conduct internal treatment campaigns; and, (4) create a researcher application program interface to enable addiction researchers to connect with the system. Currently, there is no commercially viable platform for surfacing, implementing, and tracking the efficacy of optimal therapies and tools in an application environment. Phase I will focus on determining the feasibility of this technology for unlocking scientific interventions that can be clinically validated as successful in order to expand work in phase II to prove the capacity of this system to deliver single or bivariate therapy campaigns to users while also establishing the clinical efficacy for improving health outcomes sufficient to support interventions nationwide through cost-effective treatment solutions.

小型企业创新研究(SBIR)第一阶段项目的更广泛影响/商业潜力是研究根据需要增强核心个人用户应用程序和商业后端门户产品的可行性，以增强和衡量创新成瘾治疗和康复支持工具的有效性。如果成功，这笔投资将使医疗保健利益相关者(例如，个人、成瘾和精神健康机构和提供者、健康研究人员和大学、政府机构和付款人)能够利用技术增强的成瘾治疗创新，如正念训练、应急管理、药物辅助治疗、同伴支持和适应性干预，这些创新显示出改善健康结果和交付效率的前景。拟议的创新将有助于确定开发、测试创新技术并将其商业化的可行性，这些创新技术可以提高现有卫生IT解决方案的效率，并为利益相关者创建新的解决方案，这些利益相关者对有效的干预措施和工具的需求越来越高，需要在研究和交付环境的组合中开发、提供和评估有效的成瘾治疗和康复支持服务，并能够在公共和私人成瘾康复交付环境的组合中产生可观的收入。拟议的项目将需要快速组装技术基础，然后测试支持部署和评估新颖的、基于证据的成瘾治疗策略和康复干预措施的可行性。有四个关键的研究目标：(1)设计、开发和测试一种机制，以创建具有统计学意义的队列；(2)识别和测试方法，以衡量参与者的康复和戒酒成功；(3)开展内部治疗活动；以及(4)创建研究人员应用程序接口，使成瘾研究人员能够与系统连接。目前，还没有商业上可行的平台来在应用环境中浮出水面、实施和跟踪最佳疗法和工具的疗效。第一阶段将侧重于确定这项技术用于解锁可被临床验证为成功的科学干预措施的可行性，以便扩大第二阶段的工作，以证明该系统向用户提供单变量或双变量治疗活动的能力，同时还建立通过具有成本效益的治疗解决方案改善足以支持全国干预措施的健康结果的临床疗效。